How to Buy a Mental Health Practice in 2026

Outpatient mental health is the most actively consolidating vertical in healthcare right now, and also the most misunderstood. The post-COVID surge in demand, commercial payer parity enforcement, and the rapid maturation of telehealth created a land grab between 2020 and 2023. LifeStance Health went public at a $7B valuation, Mindpath Health, Refresh Mental Health, Thriveworks, Talkiatry, Headway, and a dozen other platforms soaked up billions in growth equity, and private buyers were paying 8-12x EBITDA for practices that three years earlier traded at 4-5x.

Then interest rates went up, LifeStance lost 70% of its market cap, and several high-profile platforms restructured or sold at a loss. The froth is gone. What remains is a more rational market where a well-run outpatient practice trades at 5-8x EBITDA and the opportunity to build a regional platform is still genuinely open. Here is what a buyer needs to know in 2026.

What You Are Actually Buying

A mental health practice is a bundle of individually licensed clinicians — LCSWs, LPCs, LMFTs, psychologists (PhDs/PsyDs), psychiatric nurse practitioners, and psychiatrists — each with their own caseload, their own payer credentialing, and their own relationship with their patients. Unlike a dental practice where patients are loyal to the location, mental health patients are loyal to their specific therapist. If the therapist leaves, the patient leaves.

That means the valuation and diligence need to be done clinician-by-clinician, not at the entity level. A practice with $3M in revenue and 15 therapists is really 15 separate revenue streams, and the question you are underwriting is how many of them will still be producing on day 91 after close.

The services mix matters too. Therapy-only practices are less valuable than practices that combine therapy with psychiatric medication management (the med-mgmt side commands higher rates and has stickier patients). Practices with a psychological testing and assessment service line generate premium revenue — neuropsych batteries bill at $2,500-$5,000 and have waiting lists in most markets.

Valuation Framework

Mental health practices are valued on EBITDA once they get above roughly $500K in normalized earnings, and on SDE below that. Current ranges:

• Solo or small group therapy-only practice (under $1M revenue): 2-3.5x SDE. Heavy owner-dependency; buyer pool is other therapists.
• Multi-clinician group practice with mixed therapy and med management ($2M-$8M revenue): 5-7x EBITDA. The sweet spot for regional platform roll-ups.
• Larger platform practice ($8M-$25M revenue) with multiple locations and management infrastructure: 7-9x EBITDA.
• Platform acquisition (new PE entry): 9-11x EBITDA for the right asset. Significantly lower than the 2021-2022 peak of 12-15x.

The normalized EBITDA calculation is where most deals get mispriced. The seller's P&L usually shows the owner as a clinician drawing both a W-2 salary and a distribution. You need to replace the clinical portion with a market-rate salary (for a psychologist-owner, roughly $140K-$180K depending on geography; for a psychiatrist-owner, $260K-$340K), keep the administrative portion as an add-back, and recalculate EBITDA on that basis.

Therapist Retention Is the Entire Deal

If there is one lesson from the LifeStance and Refresh era, it is that clinician retention is the single variable that determines whether an acquisition works. Platforms that tried to standardize compensation downward, force W-2 conversions, or impose productivity quotas on 1099 therapists watched 30-50% of their clinicians walk within 18 months. That is a catastrophic outcome and it is entirely preventable.

Before you close, understand the compensation model. Mental health practices typically pay clinicians one of three ways:

• Percentage-of-collections (most common for 1099 contractors): 55-70% of what the clinician collects. Higher percentages for established clinicians with full caseloads.
• Fee-per-session (W-2): $45-$90 per session for LCSWs/LPCs, $60-$120 for psychologists, $180-$280 for psychiatrists.
• Salary with productivity bonus (W-2): Common in hospital-affiliated and larger group practices.

Whatever the model, do not change it in the first year post-close. If you need to migrate toward a different structure over time, grandfather existing clinicians and apply the new model to new hires. Make retention conversations with the top 5 producers part of your LOI-to-close period — not part of your post-close integration plan.

Non-competes in mental health are minimally useful. Even in states where they are enforceable, litigating against a therapist for taking her caseload is a PR disaster and usually a waste of legal fees. Focus your retention strategy on culture and compensation, not restrictive covenants.

Payer Credentialing and Revenue Cycle

Payer credentialing is where mental health acquisitions quietly die. Every clinician is individually credentialed with every payer they bill — BCBS, Aetna, Cigna, UHC, Optum (which manages behavioral health for many commercial payers), Medicare, and Medicaid managed care plans. When ownership changes, payers require a notification and in many cases a re-credentialing process that can take 60-180 days per payer per clinician.

If the target is structured as a professional corporation (PC) or PLLC and you can buy the equity of the entity (stock purchase), most commercial payer contracts stay in place and you avoid the credentialing nightmare. If you do an asset purchase and set up a new legal entity, you are essentially starting payer credentialing from scratch, which can destroy 6 months of cash flow. This is the single most important structural decision in a mental health deal and you need a healthcare attorney on it from day one.

Commercial reimbursement has genuinely improved since the parity enforcement actions of 2022-2024. Commercial rates for a 90837 (60-minute therapy session) now run $110-$180 in-network depending on market, and psychiatric med management (99214 plus add-ons) runs $140-$220. Medicaid managed care plans pay 50-70% of commercial rates but are increasingly important for scale, especially in states that expanded Medicaid.

The Telehealth Platform Question

Every mental health practice you buy in 2026 will have some mix of in-person and telehealth delivery. The post-COVID norm is roughly 40-70% telehealth for therapy, slightly lower for psychiatric med management. The platform question is what the target is using, and whether it is defensible.

The mainstream clinical platforms are SimplePractice, TheraNest, TherapyNotes, and Valant (larger multi-site). Each integrates scheduling, notes, e-prescribing (through DrFirst or Dr.First integrations), and billing. All are workable. Switching platforms post-close is expensive and disruptive — budget $15K-$50K and a full quarter of staff retraining if you need to migrate.

The marketplace platforms — Headway, Grow Therapy, Alma, Rula, and SonderMind — are a different animal. They handle credentialing and billing in exchange for a cut of collections, typically 20-30%. Many smaller practices have clinicians who take some of their caseload through these marketplaces. That revenue is real but it does not belong to you post-close — it belongs to the individual clinician's marketplace account. Exclude it from your valuation unless you have a clear path to migrating it to the practice's direct billing.

Diligence Checklist

• Clinician roster with credentials, employment type, tenure, caseload, and gross collections by clinician for the last 12 months.
• Payer contract list and fee schedules. Confirm whether contracts transfer under stock vs. asset structure.
• Credentialing status for every clinician with every major payer. Gaps are common and each takes months to close.
• State licensing board complaint history for every clinician.
• Malpractice claims history. Most practices use CPH&A, HPSO, or The Trust as carriers.
• HIPAA and state-specific mental health confidentiality compliance. Several states have stricter rules than HIPAA for therapy records.
• Accounts receivable aging by payer. Over-90-day balances are commonly 15-25% of A/R in this vertical and collection rates are poor.
• No-show and cancellation rates. Above 15% is a red flag about operational quality.

The Bottom Line

Mental health is a service business disguised as a healthcare business. The clinical regulations are real but secondary — the actual engine of the business is whether your therapists and psychiatrists show up on Monday morning feeling good about their jobs. Buyers who understand that and build their integration playbook around clinician experience make good returns. Buyers who treat it as a MultipleArbitrage exercise and try to squeeze margins learn the same lesson LifeStance learned. Model the deal conservatively using our valuation calculator and assume 15-20% clinician attrition in your base case.